Select Medical Holdings Revenue Growth Rates (SEM), Current and Historic Growth - CSIMarket
CSIMarket
 


Select Medical Holdings Corp  (NYSE: SEM)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

SEM's Revenue Growth by Quarter and Year

Select Medical Holdings's Revenue results by quarter and year




SEM Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 1,421.48
FY 1,421.48

SEMs Annual Revenue
Select Medical Holdings's Revenue in the fiscal year 2025 $ 5,452.83 millions
Select Medical Holdings's Revenue in the fiscal year 2024 $ 5,187.11 millions
Select Medical Holdings's Revenue in the fiscal year 2023 $ 6,664.06 millions
Select Medical Holdings's Revenue in the fiscal year 2022 $ 6,333.54 millions
Select Medical Holdings's Revenue in the fiscal year 2021 $ 6,204.52 millions




SEM Revenue first quarter 2026 Y/Y Growth Comment
Select Medical Holdings Corp reported Revenue growth of 5.05% year on year in the first quarter 2026, to $ 1,421.48 millions, this is lower than Select Medical Holdings Corp's recent average Revenue increase of 10.31%.

Looking into first quarter 2026 results within Healthcare Facilities industry 17 other companies have achieved higher Revenue growth. While Select Medical Holdings Corp' s Revenue increase of 5.05% ranks overall at the positon no. 2005 in the first quarter 2026.




SEM Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - - - 4.89 %
3rd Quarter September - -22.58 % 5.74 % 6.24 %
2nd Quarter June - -23.87 % 5.08 % 5.67 %
1st Quarter March 5.05 % -24.35 % 7.44 % 4.09 %
FY   - 5.12 % -22.16 % -

Financial Statements
Select Medical Holdings's first quarter 2026 Revenue $ 1,421.48 millions SEM's Income Statement
Select Medical Holdings's first quarter 2025 Revenue $ 1,353.17 millions Quarterly SEM's Income Statement


SEM Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 2.43 % - -0.41 %
3rd Quarter September - 1.78 % 0.09 % -0.53 %
2nd Quarter June - -1 % -1.63 % 0.57 %
1st Quarter March 1.78 % - 7.83 % 5.28 %
FY (Year on Year)   - 5.12 % -22.16 % -




Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #18
Healthcare Sector #298
Overall #2005

Revenue Y/Y Growth Statistics
High Average Low
256.63 % 10.31 % -59.42 %
(Sep 30 2018)   (Sep 30 2017)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #18
Healthcare Sector #298
Overall #2005
Revenue Y/Y Growth Statistics
High Average Low
256.63 % 10.31 % -59.42 %
(Sep 30 2018)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Select Medical Holdings's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
111.53 % 2.64 % -100 %
(Jun 30 2016)  


SEM's I. Quarter Q/Q Revenue Comment
Select Medical Holdings Corp achieved in the I. Quarter 2026 below company average Revenue growth of 1.78% quarter on quarter, to $ 1,421.48 millions.

Although the I. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the I. Quarter surge, eclipses the % growth in the I. Quarter a year ago

Within Healthcare Facilities industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Select Medical Holdings's Revenue growth quarter on quarter, overall rank is 1399.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #17
Healthcare Sector #190
Overall #1399
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #17
Healthcare Sector #190
Overall #1399
Revenue Q/Q Growth Statistics
High Average Low
111.53 % 2.64 % -100 %
(Jun 30 2016)  


SEM's I. Quarter Q/Q Revenue Comment
Select Medical Holdings Corp achieved in the I. Quarter 2026 below company average Revenue growth of 1.78% quarter on quarter, to $ 1,421.48 millions.

I. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the I. Quarter a year ago.

Within Healthcare Facilities industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Select Medical Holdings's Revenue growth quarter on quarter, overall rank is 1399.


Select Medical Holdings's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 5,521.13 $ 5,452.83 $ 3,933.61 $ 4,331.38 $ 4,751.47
Y / Y Revenue Growth (TTM) 16.2 % 5.12 % -43.55 % -36.98 % -30 %
Year on Year Revenue Growth Overall Ranking # 1129 # 992 # 1454 # 1186 # 533
Seqeuential Revenue Change (TTM) 1.25 % 38.62 % -9.18 % -8.84 % -8.4 %
Seq. Revenue Growth (TTM) Overall Ranking # 2575 # 1138 # 1871 # 1964 # 718


Cumulative Revenue growth Comment
Select Medical Holdings saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.2% year on year, to $ 5,521 millions if the fiscal year would have ended in Mar 31 2026.
Select Medical Holdings's trailing twelve months Revenue growth was higher than company's average 7.74% and higher than 5.12% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 1.25 % from $5452.83 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at7.74%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 1.25 % increase from $5452.83 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 133 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 992 to 1129.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 29
Healthcare Sector # 134
Overall # 1129

Revenue TTM Y/Y Growth Statistics
High Average Low
102.59 %
7.74 %
-62.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 370
S&P 500 # 2575
Cumulative Revenue growth Comment
Select Medical Holdings saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.2% year on year, to $ 5,521 millions if the fiscal year would have ended in Mar 31 2026.
Select Medical Holdings's trailing twelve months Revenue growth was higher than company's average 7.74% and higher than 5.12% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 1.25 % from $5452.83 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at7.74%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 1.25 % increase from $5452.83 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 133 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 992 to 1129.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 29
Healthcare Sector # 134
Overall # 1129

Revenue TTM Y/Y Growth Statistics
High Average Low
102.59 %
7.74 %
-62.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 370
S&P 500 # 2575




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SEM's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
International Stem Cell Corporation8.74%$ 8.736 millions
Warby Parker Inc 8.55%$ 8.548 millions
Iqvia Holdings Inc 8.41%$ 8.410 millions
Alpha Pro Tech Ltd 8.39%$ 8.393 millions
Nature s Sunshine Products inc 8.33%$ 8.331 millions
Viatris Inc 8.07%$ 8.072 millions
U S Physical Therapy Inc7.89%$ 7.888 millions
Vertex Pharmaceuticals Inc7.82%$ 7.823 millions
Abbott Laboratories7.78%$ 7.781 millions
Evolus Inc 7.75%$ 7.748 millions
Neuronetics Inc 7.61%$ 7.612 millions
Acadia Healthcare Company Inc 7.57%$ 7.566 millions
Merit Medical Systems Inc7.54%$ 7.542 millions
Biocryst Pharmaceuticals Inc 7.48%$ 7.475 millions
Addus Homecare Corp7.46%$ 7.462 millions
Amarin Corp Plcuk7.41%$ 7.414 millions
Steris Plc7.28%$ 7.279 millions
Mettler toledo International Inc 7.17%$ 7.172 millions
Ge Healthcare Technologies Inc 7.17%$ 7.170 millions
Bioventus Inc 7.08%$ 7.081 millions
Ardent Health Inc 6.99%$ 6.989 millions
Evofem Biosciences Inc 6.39%$ 6.391 millions
Henry Schein Inc 6.31%$ 6.313 millions
Align Technology inc 6.18%$ 6.177 millions
Davita Inc 5.96%$ 5.957 millions
American Shared Hospital Services5.82%$ 5.823 millions
Tela Bio Inc 5.76%$ 5.756 millions
Amgen Inc 5.76%$ 5.755 millions
Labcorp Holdings Inc 5.75%$ 5.755 millions
Park Dental Partners Inc 5.66%$ 5.663 millions


About Select Medical Holdings Revenue Growth Rates (SEM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Select Medical Holdings Corp (CIK 1320414).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001320414-26-000011
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Select Medical Holdings Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.